Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

General

Juul Undertaking A Reorganization, Including Necessary Step Of Separating From Many Colleagues

-Reuters

byBenzinga Newsdesk

November 10, 2022

1 minute read

-Reuters

Moderna Shares Linger At 2-Month Lows: What’s Next For The COVID-19 Vaccine Company

By Shanthi Rexaline

Today, 4:42 AM

Moderna Inc (NASDAQ: MRNA) stock is trading at its lowest level since late July. This once high-flying stock that notched up stratospheric gains from its COVID-19 program has lost altitude.

MRK

Why Chegg Shares Are Falling

By Henry Khederian

Today, 4:42 AM

Chegg Inc (NYSE: CHGG) shares are trading lower by 21.54% to $16.50 during Monday's after-hours session after the company reported fourth-quarter financial results and issued first-quarter and FY23 guidance.

CHGG

COVID-19 Tests Boost Roche’s Q1 Sales, Reaffirms FY22 Outlook

By Vandana Singh

Today, 4:42 AM

Roche Holdings AG’s (OTC:RHHBY) Q1 FY22 sales reached CHF 16.44 billion, +10% Y/Y to (11% at constant exchange rates) on…

RHHBF

MannKind Corporation And NRx Pharmaceuticals To Evaluate Feasibility Of Formulating A Dry Powder Formulation Of ZYESAMI

By Bill Haddad

Today, 4:42 AM

MannKind Corporation (NASDAQ:MNKD) has partnered with NRx Pharmaceuticals (NASDAQ:NRXP) (NRx) to evaluate the feasibility of formulating a dry powder formulation of ZYESAMI™ (aviptadil), a synthetic

MNKD

Juul Undertaking A Reorganization, Including Necessary Step Of Separating From Many Colleagues

Related Posts

Moderna Shares Linger At 2-Month Lows: What’s Next For The COVID-19 Vaccine Company

Why Chegg Shares Are Falling

COVID-19 Tests Boost Roche’s Q1 Sales, Reaffirms FY22 Outlook

MannKind Corporation And NRx Pharmaceuticals To Evaluate Feasibility Of Formulating A Dry Powder Formulation Of ZYESAMI